Disc Medicine presents eight posters highlighting updates from their clinical trials and real-world patient surveys at the ASH 2024 annual meeting, demonstrating their ongoing development of investigational treatments for hematologic diseases.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.

www.discmedicine.com

Pharmaceutical

Biopharma

Therapeutics

Disc Medicine, Inc. showcases clinical and translational data at ASH 2024 annual meeting in San Diego.

Product Description

Company Information

Product Launch Insights

Related People

Disc Medicine, Inc. showcases clinical and translational data at ASH 2024 annual meeting in San Diego.

Product Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Product Launch Insights

Related People

Company Information